In this educational video, international renowned Key Opinion Leaders address NAFLD (non alcoholic fatty liver disease), and more especially NASH (non-alcoholic steatohepatitis) and its main challenges.
---
Dans cette vidéo éducative plusieurs leaders d'opinion reconnus internationalement nous parlent des NAFLD (non alcoholic fatty liver diseases), et plus particulièrement de la NASH (stéatohépatite non-alcoolique ou "maladie du soda") et de ses principaux challenges.
---
What is NASH? (1/5): • What is NASH? The sile...
Who is at risk? (2/5): • Who is at risk for NAS...
How to improve access to NASH diagnosis? (3/5): • How to improve access ...
How to resolve NASH? (4/5): • How to resolve NASH? -...
NASH: The future (5/5): • NASH: The future - NAS...
---
Guest speakers:
Stephen A. Harrison, MD
Medical Director of Pinnacle Clinical Research
Visiting Professor of Hepatology at the Radcliffe College of Medicine, University of Oxford,
San Antonio, Texas
Marie E. Rinella, MD
Associate Professor of Medicine,
Division of Gastroenterology and Hepatology,
Northwestern University Feinberg School of Medicine,
Chicago, Illinois - USA
Arun J. Sanyal, MD
Professor Internal Medicine
Department of Gastroenterology
Virginia Commonwealth University Medical Center,
Richmond, Virginia
Kenneth Cusi, MD
Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism
The University of Florida
Gainesville, Florida
Vlad Ratziu, MD
Professor of Hepatology
Hôpital Pitié Salpêtrière, Institute of Cardiometabolism and Nutrition
Paris, France
---
Works from The NASH Education Program are the property of GENFIT and are protected by IP rights. They are reproduced with the authorization of GENFIT
24 окт 2017